Last reviewed · How we verify

Panax Ginseng — Competitive Intelligence Brief

Panax Ginseng (Panax Ginseng) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal adaptogen / botanical extract. Area: General wellness, fatigue, cognitive function, immunomodulation.

marketed Herbal adaptogen / botanical extract General wellness, fatigue, cognitive function, immunomodulation Small molecule Live · refreshed every 30 min

Target snapshot

Panax Ginseng (Panax Ginseng) — Seoul National University Hospital. Panax ginseng contains ginsenosides and other bioactive compounds that modulate immune function, reduce inflammation, and enhance stress adaptation through multiple signaling pathways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Panax Ginseng TARGET Panax Ginseng Seoul National University Hospital marketed Herbal adaptogen / botanical extract

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal adaptogen / botanical extract class)

  1. Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Panax Ginseng — Competitive Intelligence Brief. https://druglandscape.com/ci/panax-ginseng. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing